Cite
HARVARD Citation
Lelong, M. et al. (n.d.). P207 COVID-19: a prevalence rate two times lower than that of the general population in French patients with Inflammatory Bowel Disease treated with intravenous biologic agents. Journal of Crohn's and colitis. pp. i265-i266. [Online].